Mitsubishi UFJ Asset Management
OMED

Mitsubishi UFJ Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-69,700
Closed -$1.57M – 878
2015
Q2 		$1.57M Buy
69,700
+15,100
+28% +$372K 0.05% 415
2015
Q1 		$1.41M Buy
+54,600
New +$1.38M 0.04% 464

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Mitsubishi UFJ Asset Management's OMED Position: Q3 2015 in Review

Mitsubishi UFJ Asset Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2015, closing a stake of 69,700 shares — an estimated $1.57M sold.

Mitsubishi UFJ Asset Management first reported a position in OMED in Q1 2015 and held it in 2 quarters. The position peaked at $1.57M in Q2 2015. 87 funds tracked by Wall St. Rank hold OMED as of Q3 2015.

  • Mitsubishi UFJ Asset Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 69,700 OncoMed Pharmaceuticals, Inc. shares in Q3 2015, an estimated $1.57M.
  • Mitsubishi UFJ Asset Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2015 and held it in 2 quarters.
  • Mitsubishi UFJ Asset Management's OncoMed Pharmaceuticals, Inc. position peaked at $1.57M in Q2 2015.
  • 87 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2015.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2015, filed 6 Nov 2015.